EDRN Prostate & Urogenital Cancers Collaborative Group Meeting

Chair: O. John Semmes, PhD, Eastern Virginia Medical School

Co-chair: Jeff Tosoian, MD, Vanderbilt University Medical Center

NCI Program Directors: Indu Kohaar, PhD and Richard Mazurchuk, PhD, National Cancer Institute

DMCC: Yingye Zheng, PhD and Kristin Rodgers, Fred Hutchinson Cancer Center

Mountain Standard Time	Agenda Item
2:00 - 2:05 pm	Welcome

Research Updates by BCCs and CVC

Presentation should highlight progress, proposed collaborative project, and what will be gained if successful (20 min, 5 min Q&A)

Mountain Standard Time	Agenda Item
2:05 - 2:30 pm	Michigan-VUMC Biomarker Characterization Center 01: Arul M Chinnaiyan, MD, PhD; University of Michigan/Jeffrey J Tosoian, MD, MPH; Vanderbilt University Medical Center
2:30 - 2:55 pm	Emory-University of Alabama-University of Texas Southwestern Prostate Cancer Clinical Validation Center 02: Martin G Sanda, MD, Emory University
2:55 - 3:20 pm	Johns Hopkins Biomarker Characterization Center 03: Daniel W. Chan, PhD, JHU
3:20 - 3:45 pm	Virginia-UCLA-Toronto Biomarker Characterization Center 04: O. John Semmes, PhD, EVMS
3:45 - 4:00 pm	Discussion on projects for EDRN Set Aside funds request
4:00 - 4:10 pm	Break
4:10 - 4:35 pm	Prostate Clinical Utility Trial (20 min, 5 min Q&A) 05: Jeffrey J Tosoian, MD, MPH, Vanderbilt University Medical Center
4:35 - 5:00 pm	Open discussion about potential trans BRL projects, (25 min) Discussion/Brainstorming to prepare Development of a Trans-EDRN BRL Projects Moderator(s): Martin G Sanda, MD, Emory Arul M Chinnaiyan, MD, PhD, UMICH
5:00 – 5:25 pm	Open discussion on new perspectives and focus areas that can be coordinated across the group including BCCs and CVCs, (25 min) Moderator(s): Martin G Sanda, MD, Emory Arul M Chinnaiyan, MD, PhD, UMICH
5:25 – 5:50 pm	Open discussion to Identify potential uses of prostate reference sets and data, (25 min) (molecular and clinical data including image data). Moderator: Daniel W. Chan, PhD, JHU
5:50 – 6:00 pm	Other Issues